|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/75 |
| (11) | Number of the document | 2825555 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13709190.6 |
| Date of filing the European patent application | 2013-03-12 | |
| (97) | Date of publication of the European application | 2015-01-21 |
| (45) | Date of publication and mention of the grant of the patent | 2017-07-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2013/054983 |
| Date | 2013-03-12 |
| (87) | Number | WO 2013/135684 |
| Date | 2013-09-19 |
| (30) | Number | Date | Country code |
| 12159276 | 2012-03-13 | EP | |
| 201261610030 P | 2012-03-13 | US |
| (72) |
SCHULZ, Petra, AT
GEHRINGER, Werner, AT
PAPE, Rainer, AT
LEITINGER, Caroline, AT
SCHÖN, Friedrich, AT
RÖMISCH, Jürgen, AT
|
| (73) |
Octapharma AG,
Seidenstrasse 2, 8853 Lachen,
CH
|
| (54) | MPROVED PROCESS FOR PRODUCTION OF FIBRINOGEN AND FIBRINOGEN PRODUCED THEREBY |
| MPROVED PROCESS FOR PRODUCTION OF FIBRINOGEN AND FIBRINOGEN PRODUCED THEREBY |